Literature DB >> 9685617

Urinary trypsin inhibitor suppresses vascular smooth muscle contraction by inhibition of Ca2+ influx.

N Kanayama1, K Maehara, L She, H M Belayet, S Khatun, N Tokunaga, T Terao.   

Abstract

Urinary trypsin inhibitor (UTI) and its precursor form inter-alpha trypsin inhibitor (ITI) are present in plasma. To determine the action of UTI on blood vessels, we performed isometric vascular muscle contraction tests, microcirculation studies and measurement of cytosolic free Ca2+ in vascular smooth muscle cells. An isometric vascular muscle contraction test showed that the contractions stimulated by endothelin-1 or norepinephrine were suppressed in the presence of UTI, and that the contractions were not inhibited in the presence of ITI. The microcirculation study showed that the contraction of mesenteric arterioles of WKY rats induced by norepinephrine were inhibited by treatment of UTI, and that they did not alter by treatment of ITI. Pre-incubation of UTI, but not ITI, with vascular smooth muscle cells inhibited the increase of cytosolic free Ca2+ induced by endothelin-1 or norepinephrine. Cell-binding study by biotinylated UTI showed that vascular smooth muscle cells have specific binding site for UTI, but not for ITI. We propose that circulating UTI converted from ITI has a regulatory effect on local vascular tone by regulation of Ca2+ influx into smooth muscle cells. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685617     DOI: 10.1016/s0304-4165(98)00022-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain.

Authors:  Hiroshi Shigetomi; Akira Onogi; Hirotaka Kajiwara; Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Inflamm Res       Date:  2010-05-08       Impact factor: 4.575

2.  Plasma bikunin: half-life and tissue uptake.

Authors:  Aneta Kaczmarczyk; Anna M Blom; James Alston-Smith; Mats Sjöquist; Erik Fries
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

Review 3.  The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.

Authors:  Megan S Lord; James Melrose; Anthony J Day; John M Whitelock
Journal:  J Histochem Cytochem       Date:  2020-07-08       Impact factor: 2.479

4.  Inter-α-inhibitor Ameliorates Endothelial Inflammation in Sepsis.

Authors:  Vandy P Stober; Yow-Pin Lim; Steven Opal; Lisheng Zhuo; Koji Kimata; Stavros Garantziotis
Journal:  Lung       Date:  2019-04-26       Impact factor: 2.584

Review 5.  Proteoglycans in Toll-like receptor responses and innate immunity.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-08       Impact factor: 5.282

6.  Beneficial effects of trypsin inhibitors derived from a spider venom peptide in L-arginine-induced severe acute pancreatitis in mice.

Authors:  Weiwen Ning; Yongjun Wang; Fan Zhang; Hengyun Wang; Fan Wang; Xiaojuan Wang; Huaxin Tang; Songping Liang; Xiaoliu Shi; Zhonghua Liu
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

7.  Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes.

Authors:  Antonio Junior Lepedda; Gabriele Nieddu; Silvia Rocchiccioli; Nadia Ucciferri; Michela Idini; Pierina De Muro; Marilena Formato
Journal:  J Diabetes Res       Date:  2018-02-06       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.